Myeloid Cell Modulation by a GLP-1 Receptor Agonist Regulates Retinal Angiogenesis in Ischemic Retinopathy

Overview

Journal JCI Insight

Specialties Biomedical Engineering
General Medicine

Date 2021 Oct 21

PMID 34673570

Citations 12

Authors

Lingli Zhou

Zhenhua Xu

Yumin Oh

Rico Gamuyao

Grace Lee

Yangyiran Xie

Hongkwan Cho

Seulki Lee

Elia J Duh

Affiliations

Soon will be listed here.

Abstract

Ischemic retinopathies including diabetic retinopathy are major causes of blindness. Although neurons and Müller glia are recognized as important regulators of reparative and pathologic angiogenesis, the role of mononuclear phagocytes (MPs) - particularly microglia, the resident retinal immune cells - is unclear. Here, we found MP activation in human diabetic retinopathy, especially in neovessels from human neovascular membranes in proliferative retinopathy, including TNF-α expression. There was similar activation in the mouse oxygen-induced retinopathy (OIR) model of ischemia-induced neovascularization. Glucagon-like peptide-1 receptor (GLP-1R) agonists are in clinical use for glycemic control in diabetes and are also known to modulate microglia. Herein, we investigated the effect of a long-acting GLP-1R agonist, NLY01. Following intravitreal administration, NLY01 selectively localized to MPs in retina with OIR. NLY01 modulated MPs but not retinal endothelial cell viability, apoptosis, and tube formation in vitro. In OIR, NLY01 treatment inhibited MP infiltration and activation, including MP expression of cytokines in vivo. NLY01 significantly suppressed global induction of retinal inflammatory cytokines, promoted reparative angiogenesis, and suppressed pathologic retinal neovascularization. Collectively, these findings indicate the important role of mononuclear phagocytes in regulation of retinal vascularization in ischemia and suggest modulation of MPs as a potentially new treatment strategy for ischemic retinopathies.

Citing Articles

Antibody Aggregation: A Problem Within the Biopharmaceutical Industry and Its Role in AL Amyloidosis Disease.

Sheehan K, Jeon H, Corr S, Hayes J, Mok K Protein J. 2024; 44(1):1-20.

PMID: 39527351 DOI: 10.1007/s10930-024-10237-6.

Suppression of inner blood-retinal barrier breakdown and pathogenic Müller glia activation in ischemia retinopathy by myeloid cell depletion.

Zhou L, Xu Z, Lu H, Cho H, Xie Y, Lee G J Neuroinflammation. 2024; 21(1):210.

PMID: 39182142 PMC: 11344463. DOI: 10.1186/s12974-024-03190-9.

Glucagon-like peptide-1 receptor agonists rescued diabetic vascular endothelial damage through suppression of aberrant STING signaling.

He X, Wen S, Tang X, Wen Z, Zhang R, Li S Acta Pharm Sin B. 2024; 14(6):2613-2630.

PMID: 38828140 PMC: 11143538. DOI: 10.1016/j.apsb.2024.03.011.

Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions.

Shahror R, Morris C, Mohammed A, Wild M, Zaman B, Mitchell C J Neuroinflammation. 2024; 21(1):65.

PMID: 38454477 PMC: 10918977. DOI: 10.1186/s12974-024-03058-y.

PERK Inhibition Suppresses Neovascularization and Protects Neurons During Ischemia-Induced Retinopathy.

Shi S, Ding C, Zhu S, Xia F, Buscho S, Li S Invest Ophthalmol Vis Sci. 2023; 64(11):17.

PMID: 37566408 PMC: 10424802. DOI: 10.1167/iovs.64.11.17.

References

Xu Z, Gong J, Maiti D, Vong L, Wu L, Schwarz J . MEF2C ablation in endothelial cells reduces retinal vessel loss and suppresses pathologic retinal neovascularization in oxygen-induced retinopathy. Am J Pathol. 2012; 180(6):2548-60. PMC: 3378855. DOI: 10.1016/j.ajpath.2012.02.021. View

Checchin D, Sennlaub F, Levavasseur E, Leduc M, Chemtob S . Potential role of microglia in retinal blood vessel formation. Invest Ophthalmol Vis Sci. 2006; 47(8):3595-602. DOI: 10.1167/iovs.05-1522. View

Raffaele S, Lombardi M, Verderio C, Fumagalli M . TNF Production and Release from Microglia via Extracellular Vesicles: Impact on Brain Functions. Cells. 2020; 9(10). PMC: 7598215. DOI: 10.3390/cells9102145. View

Kim S, Moon M, Park S . Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease. J Endocrinol. 2009; 202(3):431-9. DOI: 10.1677/JOE-09-0132. View

Dejda A, Mawambo G, Daudelin J, Miloudi K, Akla N, Patel C . Neuropilin-1-Expressing Microglia Are Associated With Nascent Retinal Vasculature Yet Dispensable for Developmental Angiogenesis. Invest Ophthalmol Vis Sci. 2016; 57(4):1530-6. DOI: 10.1167/iovs.15-18598. View

Drucker D . Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1. Cell Metab. 2018; 27(4):740-756. DOI: 10.1016/j.cmet.2018.03.001. View

Smith L, Wesolowski E, McLellan A, Kostyk S, Damato R, Sullivan R . Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994; 35(1):101-11. View

Pierce E, Avery R, Foley E, Aiello L, Smith L . Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A. 1995; 92(3):905-9. PMC: 42729. DOI: 10.1073/pnas.92.3.905. View

Connor K, SanGiovanni J, Lofqvist C, Aderman C, Chen J, Higuchi A . Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med. 2007; 13(7):868-873. PMC: 4491412. DOI: 10.1038/nm1591. View

10.

Athauda D, Foltynie T . Protective effects of the GLP-1 mimetic exendin-4 in Parkinson's disease. Neuropharmacology. 2017; 136(Pt B):260-270. DOI: 10.1016/j.neuropharm.2017.09.023. View

11.

Thawkar B, Kaur G . Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease. J Neuroimmunol. 2018; 326:62-74. DOI: 10.1016/j.jneuroim.2018.11.010. View

12.

Stahl A, Connor K, Sapieha P, Chen J, Dennison R, Krah N . The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci. 2010; 51(6):2813-26. PMC: 2891451. DOI: 10.1167/iovs.10-5176. View

13.

Zhou T, Huang Z, Sun X, Zhu X, Zhou L, Li M . Microglia Polarization with M1/M2 Phenotype Changes in rd1 Mouse Model of Retinal Degeneration. Front Neuroanat. 2017; 11:77. PMC: 5591873. DOI: 10.3389/fnana.2017.00077. View

14.

Zhao L, Zabel M, Wang X, Ma W, Shah P, Fariss R . Microglial phagocytosis of living photoreceptors contributes to inherited retinal degeneration. EMBO Mol Med. 2015; 7(9):1179-97. PMC: 4568951. DOI: 10.15252/emmm.201505298. View

15.

Duh E, Sun J, Stitt A . Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI Insight. 2017; 2(14). PMC: 5518557. DOI: 10.1172/jci.insight.93751. View

16.

Reyes N, OKoren E, Saban D . New insights into mononuclear phagocyte biology from the visual system. Nat Rev Immunol. 2017; 17(5):322-332. PMC: 5810371. DOI: 10.1038/nri.2017.13. View

17.

Sapieha P . Eyeing central neurons in vascular growth and reparative angiogenesis. Blood. 2012; 120(11):2182-94. DOI: 10.1182/blood-2012-04-396846. View

18.

Okunuki Y, Mukai R, Nakao T, Tabor S, Butovsky O, Dana R . Retinal microglia initiate neuroinflammation in ocular autoimmunity. Proc Natl Acad Sci U S A. 2019; 116(20):9989-9998. PMC: 6525481. DOI: 10.1073/pnas.1820387116. View

19.

Hendrickx D, van Eden C, Schuurman K, Hamann J, Huitinga I . Staining of HLA-DR, Iba1 and CD68 in human microglia reveals partially overlapping expression depending on cellular morphology and pathology. J Neuroimmunol. 2017; 309:12-22. DOI: 10.1016/j.jneuroim.2017.04.007. View

20.

Frakes A, Ferraiuolo L, Haidet-Phillips A, Schmelzer L, Braun L, Miranda C . Microglia induce motor neuron death via the classical NF-κB pathway in amyotrophic lateral sclerosis. Neuron. 2014; 81(5):1009-1023. PMC: 3978641. DOI: 10.1016/j.neuron.2014.01.013. View